[caad 234]E<PAGE>
AS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION ON JANUARY 19, 2001
REGISTRATION NO. ________
================================================================================
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
-----------
FORM S-8
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
-----------
INHALE THERAPEUTIC SYSTEMS, INC.
(Exact name of registrant as specified in its charter)
DELAWARE 94-3134940
(State of incorporation) (I.R.S. Employer Identification No.)
150 INDUSTRIAL ROAD
SAN CARLOS, CALIFORNIA 94070
(650) 631-3100
(Address, including zip code, and telephone number,
including area code of principal executive offices)
2000 NON-OFFICER EQUITY INCENTIVE PLAN
(Full title of the plan)
AJIT S. GILL
CHIEF EXECUTIVE OFFICER
INHALE THERAPEUTIC SYSTEMS, INC.
150 INDUSTRIAL ROAD
SAN CARLOS, CALIFORNIA 94070
(650) 631-3100
(Name, address, including zip code, and telephone number,
including area code, of agent for service)
-----------
COPIES TO:
MARK P. TANOURY, ESQ.
JOHN M. GESCHKE, ESQ.
COOLEY GODWARD LLP
3000 SAND HILL ROAD, BLDG. 3, SUITE 230
MENLO PARK, CALIFORNIA 94025
(650) 843-5000
-----------
CALCULATION OF REGISTRATION FEE
<TABLE>
<CAPTION>
====================================================================================================================================
PROPOSED MAXIMUM PROPOSED MAXIMUM
TITLE OF SECURITIES AMOUNT TO OFFERING PRICE AGGREGATE AMOUNT OF
TO BE REGISTERED BE REGISTERED PER UNIT(1) OFFERING PRICE(1) REGISTRATION FEE
------------------------------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C> <C>
Stock Options and Common Stock (par value $.0001)...... 2,300,000 $29.75 $68,425,000 $17,106.25
</TABLE>
(1) Estimated solely for the purpose of calculating the amount of the
registration fee pursuant to Rule 457(h). The price per share and
aggregate offering price are based upon the average of the high and low
prices of Registrant's Common Stock on January 12, 2001 as reported on
Nasdaq National Market.
Approximate date of commencement of proposed sale to the public:
as soon as practicable after this Registration Statement becomes effective.
================================================================================
================================================================================
<PAGE>
INCORPORATION OF CERTAIN DOCUMENTS BY REFERENCE
The following documents filed by Inhale Therapeutic Systems, Inc., a
Delaware corporation ("INHALE") with the Securities and Exchange Commission, are
incorporated by reference into this registration statement:
(a) Inhale's Registration Statement on Form S-8 (SEC File No. 333-74669);
(b) Inhale's Registration Statement on Form S-8 (SEC File No. 333-65919); and
(c) Inhale's Registration Statement on Form S-8 (SEC File No.333-32788).
EXHIBITS
<TABLE>
<CAPTION>
EXHIBIT NUMBER EXHIBIT INDEX
-------------- --------------
<S> <C>
3.1 (1) Certificate of Incorporation of Inhale.
3.2 (1) Bylaws of Inhale.
3.3 (2) Certificate of Amendment of the Amended Certificate of Incorporation.
4.1 Reference is made to Exhibits 3.1, 3.2 and 3.3.
4.2 (3) Restated Investor Rights Agreement among Inhale and certain other persons named therein, dated April 29, 1993,
as amended October 29, 1993.
4.3 (3) Specimen stock certificate.
4.4 (4) Stock Purchase Agreement between Inhale and Pfizer Inc., dated January 18, 1995.
4.5 (5) Form of Purchase Agreement between Inhale and the individual Purchasers, dated January 28, 1997.
4.6 (6) Stock Purchase Agreement between Inhale and Capital Research and Management Company, dated December 8, 1998.
4.7 (7) Purchase Agreement among Inhale and Lehman Brothers Inc., Deutsche Bank Securities Inc. and U.S. Bancorp Piper
Jaffray Inc. dated October 6, 1999.
4.8 (7) Registration Rights Agreement among Inhale and Lehman Brothers Inc., Deutsche Bank Securities Inc. and U.S.
Bancorp Piper Jaffray Inc., dated October 13, 1999.
4.9 (7) Indenture between Inhale as Issuer and Chase Manhattan Bank and Trust Company, National Association, as
Trustee, dated October 13, 1999.
4.10 (7) Form of Inhale Registration Rights Agreement, between Inhale and Selling Shareholder, dated January 25, 2000.
4.11 (8) Purchase Agreement among Inhale and Merrill Lynch, Pierce, Fenner & Smith Incorporated, Deutsche Bank
Securities Inc., Lehman Brothers Inc., and U.S. Bancorp Piper Jaffray Inc., dated February 2, 2000.
4.12 (8) Resale Registration Rights Agreement among Inhale and Merrill Lynch, Pierce, Fenner & Smith Incorporated,
Deutsche Bank Securities Inc., Lehman Brothers Inc., and U.S. Bancorp Piper Jaffray Inc., dated February 8,
2000.
4.13 (8) Indenture between Inhale as Issuer and Chase Manhattan Bank and Trust Company, National Association, as
Trustee, dated February 8, 2000.
4.14 (2) Specimen common stock certificate.
4.15 (9) Specimen warrants to purchase shares of common stock.
4.16 (10) Purchase Agreement among Inhale and Merrill Lynch, Pierce, Fenner & Smith Incorporated, Deutsche Bank
Securities Inc., Lehman Brothers Inc., and U.S. Bancorp Piper Jaffray Inc., dated October 11, 2000.
4.17 (10) Resale Registration Rights Agreement among Inhale and Merrill Lynch, Pierce, Fenner & Smith Incorporated,
Deutsche Bank Securities, Inc., Lehman Brothers Inc., and U.S. Bancorp Piper Jaffray Inc., dated
October 17, 2000.
4.18 (10) Indenture between Inhale, as Issuer, and Chase Manhattan Bank and Trust Company, National Association, as
Trustee, dated October 17, 2000.
5.1 (11) Opinion of Cooley Godward LLP.
23.1 (11) Consent of Ernst & Young LLP, Independent Auditors.
</TABLE>
<PAGE>
<TABLE>
<S> <C>
23.2 (11) Consent of Cooley Godward LLP (included in Exhibit 5.1).
99.1 (11) Inhale's 2000 Non-Officer Equity Incentive Plan, as amended.
99.2 (11) Stock Option Agreement (Nonstatutory Stock Option) adopted for use under Inhale's
2000 Non-Officer Equity Incentive Plan, as amended.
</TABLE>
---------------------------
(1) Incorporated by reference to the indicated exhibit in Inhale's
Quarterly Report on Form 10-Q for the quarter ended June 30, 1998.
(2) Incorporated by reference to the indicated exhibit in Inhale's
Quarterly Report on Form 10-Q for the quarter ended June 30, 2000.
(3) Incorporated by reference to the indicated exhibit in Inhale's
Registration Statement on Form S-1 (No. 33-75942), as amended.
(4) Incorporated by reference to the indicated exhibit in Inhale's
Registration Statement on Form S-1 (No. 33-89502), as amended.
(5) Incorporated by reference to Inhale's Registration Statement on
Form S-3 (No. 333-20787).
(6) Incorporated by reference to the indicated exhibit in Inhale's
Registration Statement on Form S-3 (No. 333-68897), as amended.
(7) Incorporated by reference to the indicated exhibit in Inhale's
Registration Statement on Form S-3 (No. 333-94161), as amended.
(8) Incorporated by reference to the indicated exhibit in Inhale's Annual
Report on Form 10-K for the year ended December 31, 1999.
(9) Incorporated by reference to the indicated exhibit in Inhale's
Quarterly Report on Form 10-Q for the quarter ended September 30, 2000.
(10) Incorporated by reference to the indicated exhibit in Inhale's
Registration Statement on Form S-3 (No. 333-53678).
(11) Filed herewith.
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, as amended,
the registrant certifies that it has reasonable grounds to believe that it meets
all of the requirements for filing on Form S-8 and has duly caused this
registration statement to be signed on its behalf by the undersigned, thereunto
duly authorized, in the City of San Carlos, County of San Mateo, State of
California, on the 17th day of January 2001.
INHALE THERAPEUTIC SYSTEMS, INC.
By /s/ Ajit S. Gill
-----------------------------
Ajit S. Gill
Chief Executive Officer,
President and Director
POWER OF ATTORNEY
KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature
appears below constitutes and appoints Robert B. Chess, Ajit S. Gill, Brigid A.
Makes, and each of them, as his or her true and lawful attorneys-in-fact and
agents, with full power of substitution and resubstitution, for him or her and
in his or her name, place and stead, in any and all capacities, to sign any and
all amendments (including post-effective amendments, exhibits thereto and other
documents in connection therewith) to this registration statement and any
subsequent registration statement filed by the registrant pursuant to Securities
and Exchange Commission Rule 462, which relates to this registration statement
and to file the same, with all exhibits thereto and other documents in
connection therewith, with the Securities and Exchange Commission, granting unto
said attorneys-in-fact and agents, and each of them, full power and authority to
do and perform each and every act and thing requisite and necessary to be done
in connection therewith, as fully to all intents and purposes as he or she might
or could do in person, hereby ratifying and confirming all that said
attorneys-in-fact and agents, or any of them, or their or his or her substitute
or substitutes, may lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Act of 1933, this
registration statement has been signed by the following persons in the
capacities and on the dates indicated.
<TABLE>
<CAPTION>
SIGNATURE TITLE DATE
--------- ----- ----
<S> <C> <C>
/s/ Ajit S. Gill Chief Executive Officer, President and Director January 17, 2001
--------------------- (Principal Executive Officer)
Ajit S. Gill
/s/ Robert B. Chess
-------------------- Chairman of the Board January 17, 2001
Robert B. Chess
/s/ Brigid A. Makes Chief Financial Officer and Vice President (Principal January 17, 2001
-------------------- Financial and Accounting Officer)
Brigid A. Makes
/s/ John S. Patton
-------------------- Director and Vice President January 17, 2001
John S. Patton
/s/ James B. Glavin
-------------------- Director January 17, 2001
James B. Glavin
</TABLE>
<PAGE>
<TABLE>
<S> <C> <C>
/s/ Melvin Perelman
-------------------- Director January 17, 2001
Melvin Perelman
/s/ Irwin Lerner
-------------------- Director January 17, 2001
Irwin Lerner
/s/ Roy A. Whitfield
--------------------- Director January 17, 2001
Roy A. Whitfield
</TABLE>
<PAGE>
INDEX TO EXHIBITS
<TABLE>
<CAPTION>
EXHIBIT NUMBER EXHIBIT INDEX
-------------- --------------
<S> <C>
3.1 (1) Certificate of Incorporation of Inhale.
3.2 (1) Bylaws of Inhale.
3.3 (2) Certificate of Amendment of the Amended Certificate of Incorporation.
4.1 Reference is made to Exhibits 3.1, 3.2 and 3.3.
4.2 (3) Restated Investor Rights Agreement among Inhale and certain other persons named therein, dated April 29, 1993,
as amended October 29, 1993.
4.3 (3) Specimen stock certificate.
4.4 (4) Stock Purchase Agreement between Inhale and Pfizer Inc., dated January 18, 1995.
4.5 (5) Form of Purchase Agreement between Inhale and the individual Purchasers, dated January 28, 1997.
4.6 (6) Stock Purchase Agreement between Inhale and Capital Research and Management Company, dated December 8, 1998.
4.7 (7) Purchase Agreement among Inhale and Lehman Brothers Inc., Deutsche Bank Securities Inc. and U.S. Bancorp Piper
Jaffray Inc. dated October 6, 1999.
4.8 (7) Registration Rights Agreement among Inhale and Lehman Brothers Inc., Deutsche Bank Securities Inc. and U.S.
Bancorp Piper Jaffray Inc., dated October 13, 1999.
4.9 (7) Indenture between Inhale as Issuer and Chase Manhattan Bank and Trust Company, National Association, as
Trustee, dated October 13, 1999.
4.10 (7) Form of Inhale Registration Rights Agreement, between Inhale and Selling Shareholder, dated January 25, 2000.
4.11 (8) Purchase Agreement among Inhale and Merrill Lynch, Pierce, Fenner & Smith Incorporated, Deutsche Bank
Securities Inc., Lehman Brothers Inc., and U.S. Bancorp Piper Jaffray Inc.,dated February 2, 2000.
4.12 (8) Resale Registration Rights Agreement among Inhale and Merrill Lynch, Pierce, Fenner & Smith Incorporated,
Deutsche Bank Securities Inc., Lehman Brothers Inc., and U.S. Bancorp Piper Jaffray Inc., dated
February 8, 2000.
4.13 (8) Indenture between Inhale as Issuer and Chase Manhattan Bank and Trust Company, National Association, as
Trustee, dated February 8, 2000.
4.14 (2) Specimen common stock certificate.
4.15 (9) Specimen warrants to purchase shares of common stock.
4.16 (10) Purchase Agreement among Inhale and Merrill Lynch, Pierce, Fenner & Smith Incorporated, Deutsche Bank
Securities Inc., Lehman Brothers Inc., and U.S. Bancorp Piper Jaffray Inc., dated October 11, 2000.
4.17 (10) Resale Registration Rights Agreement among Inhale and Merrill Lynch, Pierce, Fenner & Smith Incorporated,
Deutsche Bank Securities, Inc., Lehman Brothers Inc., and U.S. Bancorp Piper Jaffray Inc.,
dated October 17, 2000.
4.18 (10) Indenture between Inhale, as Issuer, and Chase Manhattan Bank and Trust Company, National Association, as
Trustee, dated October 17, 2000.
5.1 (11) Opinion of Cooley Godward LLP.
23.1 (11) Consent of Ernst & Young LLP, Independent Auditors.
23.2 (11) Consent of Cooley Godward LLP (included in Exhibit 5.1).
99.1 (11) Inhale's 2000 Non-Officer Equity Incentive Plan, as amended.
99.2 (11) Stock Option Agreement (Nonstatutory Stock Option) adopted for use under Inhale's 2000 Non-Officer
Equity Incentive Plan, as amended.
</TABLE>
---------------------------
(1) Incorporated by reference to the indicated exhibit in Inhale's
Quarterly Report on Form 10-Q for the quarter ended June 30, 1998.
<PAGE>
(2) Incorporated by reference to the indicated exhibit in Inhale's
Quarterly Report on Form 10-Q for the quarter ended June 30, 2000.
(3) Incorporated by reference to the indicated exhibit in Inhale's
Registration Statement on Form S-1 (No. 33-75942), as amended.
(4) Incorporated by reference to the indicated exhibit in Inhale's
Registration Statement on Form S-1 (No. 33-89502), as amended.
(5) Incorporated by reference to Inhale's Registration Statement on
Form S-3 (No. 333-20787).
(6) Incorporated by reference to the indicated exhibit in Inhale's
Registration Statement on Form S-3 (No. 333-68897), as amended.
(7) Incorporated by reference to the indicated exhibit in Inhale's
Registration Statement on Form S-3 (No. 333-94161), as amended.
(8) Incorporated by reference to the indicated exhibit in Inhale's Annual
Report on Form 10-K for the year ended December 31, 1999.
(9) Incorporated by reference to the indicated exhibit in Inhale's
Quarterly Report on Form 10-Q for the quarter ended September 30, 2000.
(10) Incorporated by reference to the indicated exhibit in Inhale's
Registration Statement on Form S-3 (No. 333-53678).
(11) Filed herewith.
